Key Metrics of BioMarin Pharmaceutical
Revenue$2.4B▲ 15.4% YoYFY 2023
Operating income$186M▲ 15.4% YoY
Net profit$168M▲ 18.4% YoY
Shareholders' equity$5.0B
Market cap$10.8BBMRN · $55.75
Competitors10identified
About BioMarin Pharmaceutical
Sectors
Company details
- Website
- biomarin.com
- Founded
- 1999
- Listed
- Nasdaq: BMRN (since 1999)
Operational Areas of BioMarin Pharmaceutical
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameBioMarin Pharmaceutical Inc.
TickerBMRN
ExchangeNasdaq
CountryUnited States
SEC CIK0001048477
Listed since1999
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Websitehttp://www.biomarin.com
US market & SEC filings
BMRN · Nasdaq · SEC CIK 0001048477
Last price · 27 Oct 2026
$55.75
−0.36%
Market cap$10.8B
P/E64.1On FY 2023 diluted EPS
Volume2,361,044
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOUnited StatesListed 1999
BMRN share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeNovato
GSTIN—
Email—
Websitehttp://www.biomarin.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of BioMarin Pharmaceutical
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Part of Vertex Pharmaceuticals. | vrtx.com | 1991 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | modernatx.com | 2018 | United States | |
 Becton Dickinson |
Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bd.com | — | United States |
| Part of Illumina. | illumina.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | guardanthealth.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | revvity.com | — | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | exelixis.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | neurocrine.com | 1996 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bio-rad.com | 1980 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | twistbioscience.com | 2018 | United States |
Similar companies
K
Kbk Biotech Private LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
C
Concord Biotech LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
B
Bio-Rad LaboratoriesPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
P
Precigen, IncPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
I
International Biotech Park LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
B
Bharat Immunologicals And Biologicals Corporation LimitedPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
B
Beam TherapeuticsPharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
T
Twist BiosciencePharmaceuticals & Healthcare
Same segment: Biotechnology & Vaccines
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Business activities and related parties
biotechnology
Filings
No filings on record yet.